Delivery Order SPE2DR25D1021-SPE2DR26FNT3X
Award Date 2/9/26
Potential Completion Date 2/10/26
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $2,924.26 delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for atropine 1 mg/ml vial supply, with ultimate completion by February 11, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at $999,999,999.00 running through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp on January 6, 2026, for the supply of Atropine 8 mg/20 ml vials with a ceiling value of $2,423.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of parent company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Atropine 8 mg/20 ml vials. This firm fixed-price delivery order, valued at $1,458.66, is scheduled for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order valued at $3,732.22 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This non-competitive delivery order utilizes firm fixed pricing and was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/mL vials with a ceiling value of $1,140.67 under a firm fixed price contract. The delivery order, issued on October 30, 2025, has an ultimate completion date of October 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was not set aside for small business or other designated categories, reflecting open competitive procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.07 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This firm fixed price contract, with an ultimate completion date of November 28, 2025, represents a non-competitive, non-set-aside procurement executed on November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $2,074.04 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Atropine 1 mg/mL in vial form, with an ultimate completion date of September 18, 2025. This competitive award utilizes firm fixed-price pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.74 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on January 28, 2026, with a completion date of January 29, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for a critical pharmaceutical commodity. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,690.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Atropine 1 mg/mL vials. This is a non-set-aside competitive award with an ultimate completion date of January 30, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 21, 2025, procures Atropine 1 mg/mL vials for the Defense Department's Medical Supply Chain with a ceiling value of $16,886.37. The contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...